Showing results (261-270 of 301) with videos related to

Sort By:
Pageof 31
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 1, 2014
Leveraging technology: creating and sustaining changes for healthDeydre S Teyhen, Matt Aldag, Elton Edinborough, et al.
BJU International|March 31, 2015
Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-upEila Watson, Bethany Shinkins, Emma Frith, et al.
BMJ Open|May 24, 2014
PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trialEila Watson, Peter Rose, Emma Frith, et al.
The Lancet. Oncology|December 3, 2014
Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 studyDavid Neal Franz, Elena Belousova, Steven Sparagana, et al.
Plos One|September 15, 2011
Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decreaseSandra L Dabora, David Neal Franz, Stephen Ashwal, et al.
The Journal of Orthopaedic and Sports Physical Therapy|May 3, 2014
Key enablers to facilitate healthy behavior change: workshop summaryDeydre S Teyhen, Matt Aldag, Damon Centola, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 15, 2018
Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experienceDarcy A Krueger, Jamie K Capal, Paolo Curatolo, et al.
Military Medicine|December 4, 2014
Incentives to create and sustain healthy behaviors: technology solutions and research needsDeydre S Teyhen, Matt Aldag, Damon Centola, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic reviewLina Chen, George Davey Smith, David M Evans, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|January 23, 2018
Supporting prostate cancer survivors in primary care: Findings from a pilot trial of a nurse-led psycho-educational intervention (PROSPECTIV)Eila K Watson, Bethany Shinkins, Lauren Matheson, et al.
Pageof 31